Use access key #2 to skip to page content.
$0.82 -0.05 (-5.76%)
1/7/2009 3:59 PM

Dynavax Technologies Corp (DVAX)

CAPS Rating:
***

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

View All Commentary (DVAX)

Recs

0

Avatar wontfindaname (< 20) Submitted: 3/18/08 5:49 PM : Outperform Start Price: $2.46 DVAX Score: -30.95

Expect the huge gap to get filled over the next few days and a slow rise back to 6 over the next couple of months.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links